دورية أكاديمية
A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma
| العنوان: | A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma |
|---|---|
| المؤلفون: | Mayer, E.L., DeMichele, A., Rugo, H.S., Miller, K., Waks, A.G., Come, S.E., Mulvey, T., Jeselsohn, R., Overmoyer, B., Guo, H., Barry, W.T., Huang Bartlett, C., Koehler, M., Winer, E.P., Burstein, H.J. |
| المساهمون: | Pfizer |
| المصدر: | Annals of Oncology ; volume 30, issue 9, page 1514-1520 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2019 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1093/annonc/mdz198 |
| DOI: | 10.1093/annonc/mdz198/28879400/mdz198.pdf |
| الإتاحة: | https://doi.org/10.1093/annonc/mdz198Test https://api.elsevier.com/content/article/PII:S0923753419459899?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753419459899?httpAccept=text/plainTest http://academic.oup.com/annonc/article-pdf/30/9/1514/30092870/mdz198.pdfTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.18E13C29 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1093/annonc/mdz198 |
|---|